RNAi Therapeutics

    Vutrisiran

    Vutrisiran is a quarterly injection.

    Written by the Script Unlock editorial teamNot yet reviewed by an independent pharmacist

    This page is general information about a medication and how cash prices for it are set. It is not medical advice and does not replace the label, your prescriber or your pharmacist. How we handle medical information

    Brand names
    Amvuttra
    Generic available in the US
    Check the FDA Orange Book
    Common strengths
    25mg SC every 3 months
    Commonly prescribed for
    Hereditary ATTR Amyloidosis

    About Vutrisiran

    Vutrisiran is a quarterly injection.

    Vutrisiran silences TTR mRNA.

    A full cash-pay guide for Vutrisiran has not been written yet. The facts above come from the medication catalogue; confirm details against the FDA-approved label on DailyMed.

    How Script Unlock gets you a cash price for Vutrisiran

    Prices on this site come from pharmacies responding to a real prescription. We do not publish estimated, average or "typical" prices, because none of those would be your price.

    1. 1You upload your prescription

      A photo of your Vutrisiran prescription is enough. Nothing is sold on the site; you are asking pharmacies to quote.

    2. 2Licensed pharmacies respond

      Pharmacies that Script Unlock has verified see the request and each can reply with its own cash price for your exact drug, strength and quantity.

    3. 3You choose and pay the pharmacy

      You compare the responses, pick a pharmacy, and pay that pharmacy directly when you collect. Script Unlock never takes a patient payment and never sets the price.

    Script Unlock is a marketplace that lets licensed pharmacies quote a cash price on your prescription. It does not prescribe, dispense or sell medication, does not process patient payments, and does not give medical advice. Always follow the instructions of your prescriber and pharmacist and read the medication guide supplied with your medicine.